$AGIJ DD 11/19/2012  New Investor Relations firm 

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Recent Trading Momentum for AbbVie Inc AbbVie Inc (NYSE: ABBV) has caught the attention of traders with significant fluctuations in stock prices, predominantly influenced by notable trading signals. Recently, the stock experienced an impressive Power Inflow alert, which traders regard as a critical bullish indicator. This alert hinges on valuable order flow analytics that...

Ormat Technologies' Strong Performance in 2024 Ormat Technologies, Inc. (NYSE: ORA), a prominent player in the renewable energy sector, has recently released its financial performance report for the fourth quarter and full year of 2024. This announcement marks another year of substantial growth, driven by a robust strategic approach that enhances its operational...

Current Stock Performance of State Street Currently, State Street Inc. (NYSE: STT) has a share price of $112.20, experiencing a minor decline of 0.21%. Despite this slight drop, it’s encouraging to note that the stock has seen an increase of 0.87% over the past month and a significant growth of 29.33% in the past year. This variability poses an intriguing question for...

Fortrea Welcomes Erin L. Russell to Its Board of Directors In an exciting new development, Fortrea has recently appointed Erin L. Russell to its Board of Directors, signaling a robust commitment to enhancing its strategic direction and governance. This decision comes as part of a collaboration with Starboard Value LP, an investment firm that holds a significant stake in...

Understanding Laureate Education's Market Position Laureate Education Inc (NYSE: LAUR) has recently shown a decline in its short percent of float, which has dropped 7.46% since the last report. Currently, the company indicates that it has 2.44 million shares sold short. This accounts for about 2.11% of all shares available for trading. Given its current trading volume, it...